The disease COVID-19 is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). The virus was first identified at the beginning of 2020, and has since gone on to cause a pandemic. It is currently believed that SARS-CoV-2 is an example of a zoonosis.Throughout 2020, much of the world’s medical scientific community was devoted to developing a vaccine for SARS-CoV-2. To evaluate the effectiveness of new vaccines, both humoral and cell-mediated responses are measured in animal subjects. Identify the cell type that is involved in both responses, and explain its role in each.
Question
The disease COVID-19 is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). The virus was first identified at the beginning of 2020, and has since gone on to cause a pandemic. It is currently believed that SARS-CoV-2 is an example of a zoonosis.Throughout 2020, much of the world’s medical scientific community was devoted to developing a vaccine for SARS-CoV-2. To evaluate the effectiveness of new vaccines, both humoral and cell-mediated responses are measured in animal subjects. Identify the cell type that is involved in both responses, and explain its role in each.
Solution
The cell type that is involved in both humoral and cell-mediated responses is the T lymphocyte, also known as a T cell.
In the humoral response, T cells play a crucial role in the activation of B cells, which are the cells responsible for producing antibodies. This process begins when a B cell recognizes and binds to an antigen. However, in order to produce antibodies, the B cell requires further activation, which is provided by helper T cells. Specifically, a type of helper T cell known as a follicular helper T cell (Tfh) binds to the B cell and delivers signals that trigger the B cell to proliferate and differentiate into plasma cells, which produce antibodies.
In the cell-mediated response, T cells are directly involved in the destruction of infected cells. This process is carried out by cytotoxic T cells, which recognize and kill cells that are infected with viruses. The cytotoxic T cells are able to recognize infected cells because these cells present fragments of the virus on their surface. When a cytotoxic T cell recognizes these viral fragments, it binds to the infected cell and releases toxic substances that induce the cell to undergo apoptosis, or programmed cell death.
Therefore, T cells play a central role in both the humoral and cell-mediated immune responses, helping to coordinate the immune system's response to infection.
Similar Questions
Monoclonal antibodies (mAbs) neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were the first antiviral drugs specifically developed for the treatment and prophylaxis of coronavirus disease 2019 (COVID-19) (1). Emergence of variants of concern (VOC) resistant to such antibodies on population level, however, limits their broad applicability. The Omicron variants, for example, are only neutralized by a small subset of monoclonal antibodies developed for the treatment of SARS-CoV-2 infections (2, 3). As more variants emerge, having a repertoire of monoclonal antibodies targeting different sites of the Spike protein may become useful. Therefore, we explored the prophylactic efficacy of two monoclonal antibodies targeting the receptor binding domain (RBD) of SARS-CoV-2 in a nonhuman primate model of SARS-CoV-2 infection. We additionally investigated their genetic barrier to resistance in vivo and in vitro.
The animal host for SARS-CoV-2 is the . After circulating among these animals in the wild for a long period of time, the virus accumulated mutations that allowed infection of humans.
The coronavirus disease 2019 (COVID-19) pandemic challenged the work-ings of human society, but in doing so, it advanced our understanding ofthe ecology and evolution of infectious diseases. Fluctuating transmissionof severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demon-strated the highly dynamic nature of human social behavior, often withoutgovernment intervention. Evolution of SARS-CoV-2 in the first two yearsfollowing spillover resulted primarily in increased transmissibility, while inthe third year, the globally dominant virus variants had all evolved substantialimmune evasion. The combination of viral evolution and the buildup of hostimmunity through vaccination and infection greatly decreased the realizedvirulence of SARS-CoV-2 due to the age dependence of disease severity. TheCOVID-19 pandemic was exacerbated by presymptomatic, asymptomatic,and highly heterogeneous transmission, as well as highly variable diseaseseverity and the broad host range of SARS-CoV-2. Insights and tools de-veloped during the COVID-19 pandemic could provide a stronger scientificbasis for preventing, mitigating, and controlling future pandemics.
One type of COVID-19 vaccine, developed by both Pfizer BioNTech and Moderna, consists of coding for the spike protein of SARS-CoV-2 encased in a lipid envelope.
The influenza and SARS-CoV-2 viruses have become extremely prevalent in the human population. Many people receive vaccines yearly to help prevent symptoms or infections. What is the role of the vaccine to help fight off a viral infection?Select one:a.The vaccine infects the host cell and causes the cells to lyse.b.The vaccine stimulates the production of antibodies for a specific virus.c.The vaccine creates more white blood cells.d.The vaccine engulfs the virus once it enters the body.
Upgrade your grade with Knowee
Get personalized homework help. Review tough concepts in more detail, or go deeper into your topic by exploring other relevant questions.